Is thymopeptide enteric-coated tablet a hormonal drug?

Under normal circumstances, thymopeptide enteric-coated tablets are not classified as hormonal drugs. The detailed analysis is as follows:

Thymopeptide enteric-coated tablets do not belong to the category of hormonal drugs; there are clear differences between the two in terms of composition, mechanism of action, and clinical applications. In terms of composition, thymopeptide enteric-coated tablets primarily contain thymopeptide, an active ingredient derived from thymus tissue, which is a biologically active peptide with immunomodulatory effects. In contrast, hormonal drugs—such as glucocorticoids—are bioactive substances secreted by endocrine organs like the adrenal cortex and exert broad physiological effects. Regarding mechanism of action, thymopeptide enteric-coated tablets mainly function by enhancing the body's immune function, promoting the maturation and differentiation of T lymphocytes, and improving cellular immunity.

Hormonal drugs, on the other hand, primarily exert therapeutic effects by regulating metabolic processes and inflammatory responses, with a broader range of actions. In clinical practice, thymopeptide enteric-coated tablets are mainly used to treat immunodeficiency disorders and autoimmune diseases. Hormonal drugs, however, are widely used in treating various conditions, including inflammatory diseases, allergic disorders, and immune-related diseases.

Before using thymopeptide enteric-coated tablets, patients should consult a qualified physician to determine whether and how to use the medication based on their individual health status, ensuring safe and effective treatment.